Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs. Late Abciximab in Primary PCI
NCT00354406Phase 4Completed
- Sponsor
- University of Pisa
- Start
- Apr 2006
- Primary completion
- Nov 2008
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of abciximab in myocardial infarction (MI), sponsored by University of Pisa. Primary endpoint: Infarct size (% of left ventricular mass) at 6 months. Started Apr 2006; status: completed.
02
Drugs
abciximab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00354406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354406.